entertainment -WSS

entertainment

author：knowledge 2025-08-08 10:31:22 - browse：45

A person reaching for a bottle of lipitor. -- first opinion coverage from STAT — John Moore/Getty Images

The antibiotics crisis is a silent pandemic that threatens to knock modern society back into the medieval age of therapeutic leaches and serum therapy. A world where an accidental scratch in the rose garden can kill.

Why is the supply of new antibiotics so thin, and growing thinner? A high-profile Wall Street Journal article recently highlighted what everyone knows: There is huge need but no market demand.

There are many interrelated causes. Doctors prefer to keep novel antibiotics in reserve, as a last-resort option, limiting sales volumes. Insurance companies like novel antibiotics that prevent costly ICU stays, but they’re used to the cheap price of older generics and balk at any price that allows recoupment of the full cost of development. Low prices and small volumes are a great recipe for insolvency as Achaogen’s experience showed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： 6 phony surgeries that take placebo to the extreme

WSS

Alabama hospital puts IVF treatments on hold

Abbott's new stent may help patients with peripheral artery disease

Obesity drugs seen as possible treatment for liver disease MASH

As H5N1 spreads in cows, experts warn against drinking raw milk

Alabama IVF ruling threatens families facing fatal genetic disease

Why palliative psychiatry is worth discussing

leisure time

entertainment

leisure time

How one medical school became remarkably diverse

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

In Memoriam: Notable people who died in 2023

Alabama hospital puts IVF treatments on hold

Peter Hotez and the public health issue of online harassment

Community Health Systems hospitals under DOJ investigation

How to save PrEP access — and even expand it

Alabama hospital puts IVF treatments on hold

Anesthesiologist group: stop taking Ozempic before surgery

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

focus

PBM reform efforts get punted in Congress

WuXi Biologics execs register to lobby as Congress comes for the company

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

NIH study of ME/CFS points to clear biological hallmarks

entertainment

leisure time

explore

hotspot